LIXTE Biotechnology plans to invest 25% of its treasury in Bitcoin and other cryptocurrencies

PANews reported on August 13th that the board of directors of biopharmaceutical company LIXTE Biotechnology Holdings has approved a strategic capital allocation plan to invest up to 25% of the company's treasury in cryptocurrencies, including Bitcoin and other digital assets. The specific transaction size and timing will be determined based on market conditions and strategic considerations.

Share to:

Author: PA一线

This content is for market information only and is not investment advice.

Follow PANews official accounts, navigate bull and bear markets together
PANews APP
In the past 24 hours, a total of $61.9439 million in contracts were liquidated across the entire network, including both long and short positions.
PANews Newsflash